Key Segmentation
By Type
-
Conventional Syringes
-
Safety Syringes
-
Insulin Syringes
-
Prefillable Syringes
-
Others
By Capacity
-
Up to 1 mL
-
1 mL to 5 mL
-
6 mL to 10 mL
-
11 mL to 20 mL
-
Above 20 mL
By Application
-
Vaccines and Immunization
-
Drug Delivery
-
Diagnostics and Blood Sampling
-
Diabetes Management
-
Others
By End User
-
Hospitals
-
Home Healthcare and Clinics
-
Ambulatory Surgical Centers
-
Research Institutions
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is expected to grow at a CAGR of 7.88% from 2026 to 2035.
The market was valued at USD 17.10 Billion in 2025.
Rising global prevalence of injectable-dependent chronic diseases including diabetes, cancer, and autoimmune conditions creating consistent high-volume injection requirements.
Conventional Syringes dominated with approximately 54% share in 2025.
North America dominated the market with approximately 38% of revenues in 2025.